FDA Approves First RSV Vaccine for Pregnancy
The vaccine can be given after 32 weeks of pregnancy and is designed to protect infants from respiratory syncytial virus from birth to 6 months of age.
Stay updated with breaking news from Pre Eclampsia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The vaccine can be given after 32 weeks of pregnancy and is designed to protect infants from respiratory syncytial virus from birth to 6 months of age.
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. Pre-Eclampsia Prevention The Story: The Federal Drug Administration (FDA) recently approved a new blood test that can accurately identify pregnant individuals at a greater risk of pre-eclampsia. The approval comes just months after Olympic gold
Ceri Richardson, from Cardiff, has told how she had a headache which she put down to "kids screaming" at a school sport's day but she later found that she had a potentially life threatening condition
A pregnant woman has issued a warning to other expectant mothers after her seemingly innocent headache turned out to be a symptom of a serious and potentially deadly condition.
The FDA approved a blood test identifying pregnant women at immediate risk of developing pre-eclampsia.